- This event has passed.
Protecting Patients with NERLYNX the only HER2-directed small molecule approved by the FDA in both eBC and mBC
August 13, 2020 @ 6:00 pm - 7:00 pm
Presented by: Dr. Francis Arena, NYU Langone Arena Oncology, Lake Success, New York
Sponsored by PUMA Biotechnology, Inc.
Thursday, August 13, 2020 at 6:00pm-PDT
The topics below will be covered:
– Current unmet need in HER2+ Breast Cancer
– Review of clinical outcomes
– Tolerability management and support tools
To register click HERE.